Panacea Index Logo

Command Palette

Search for a command to run...

Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline.

ESMO open
April 1, 2023
L Grassi et al. (11 authors)
Practice GuidelineResearch Support, Non-U.S. Gov'tJournal ArticleHuman StudyClinical
Study Details

Study Goal

The researchers aimed to evaluate the effectiveness of mindfulness-based therapies in treating anxiety and depressive disorders in patients with cancer.

Results Summary

The study found that mindfulness-based therapies are effective treatments for anxiety and depressive disorders in cancer patients, alongside psychotherapy and cognitive behavioral therapy. Psychopharmacological treatments were also noted as effective.

Population

Patients with cancer experiencing anxiety and depressive disorders.

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (4)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Psychotherapy
decrease
anxiety and depressive disorders
patients with cancer
-
effective treatments
#1
cognitive behavioural therapy
decrease
anxiety and depressive disorders
patients with cancer
-
effective treatments
#2
mindfulness-based therapies
decrease
anxiety and depressive disorders
patients with cancer
-
effective treatments
#3
Psychopharmacological treatments
decrease
anxiety and depressive disorders
-
-
effective treatments
#4
Abstract

• Anxiety and depressive disorders are common in patients with cancer. • A higher prevalence seen in patients with cancer than the general population is often underrecognised. • Psychotherapy, cognitive behavioural therapy and mindfulness-based therapies are effective treatments. • Psychopharmacological treatments have been shown to be effective treatments of anxiety and depressive disorders.

Medical Subject Headings (MeSH)
HumansAdultDepressionNeoplasmsAnxiety
Study Links
Quality Scores
SafetyNot Assessed
Efficacy80/10
Quality70/10
Citation Metrics
Total Citations69
Citations/Year34.5
Relative Citation Ratio15.95
NIH Percentile99.1%
Research Impact Scores
APT Score0.95
Weight Score2.99
Normalized Score0.66
Related Supplements